AtriCure | 当期純利益



Net Income 変化する 日付
Abbott USD 9.23B 7.58B 2024-12
AtriCure USD -15568000 7.72M 2024-12
Baxter International USD -512000000 652M 2024-12
Becton, Dickinson and Co. USD 303M 97M 2024-12
Boston Scientific USD 566M 97M 2024-12
Cooper Companies USD 104.3M 13.2M 2025-01
Dexcom USD 151.7M 17.1M 2024-12
Edwards Lifesciences USD 385.6M 2.69B 2024-12
Globus Medical USD 26.5M 25.33M 2024-12
Insulet USD 100.7M 23.2M 2024-12
Integra LifeSciences USD 19.43M 30.13M 2024-12
Intuitive Surgical USD 685.7M 120.6M 2024-12
J&J USD 3.43B 737M 2024-12
Masimo USD -349600000 359.4M 2024-12
Medtronic USD 1.29B 25M 2025-01
Merit Medical Systems USD 27.95M 497K 2024-12
ResMed USD 344.62M 33.27M 2024-12
Stryker USD 546M 288M 2024-12
Tandem Diabetes Care USD 755K 24.01M 2024-12
Teleflex USD -136656000 247.66M 2024-12
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12



AtriCure 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.